241 related articles for article (PubMed ID: 31493486)
21. [Interleukin-33: Friend or Enemy in the Fight against Tumors?].
Gorbacheva AM; Mitkin NA
Mol Biol (Mosk); 2019; 53(5):774-789. PubMed ID: 31661477
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.
Lin Y; Xu J; Lan H
J Hematol Oncol; 2019 Jul; 12(1):76. PubMed ID: 31300030
[TBL] [Abstract][Full Text] [Related]
23. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies.
Schirrmacher V
Adv Cancer Res; 1985; 43():1-73. PubMed ID: 2581423
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of the cell-mediated immune response to tumour growth.
López ÁG; Seoane JM; Sanjuán MAF
Philos Trans A Math Phys Eng Sci; 2017 Jun; 375(2096):. PubMed ID: 28507236
[TBL] [Abstract][Full Text] [Related]
25. Multifaceted kinetics of immuno-evasion from tumor dormancy.
d'Onofrio A
Adv Exp Med Biol; 2013; 734():111-43. PubMed ID: 23143978
[TBL] [Abstract][Full Text] [Related]
26. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.
Bleau AM; Agliano A; Larzabal L; de Aberasturi AL; Calvo A
Histol Histopathol; 2014 Dec; 29(12):1499-510. PubMed ID: 24887025
[TBL] [Abstract][Full Text] [Related]
27. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
28. Myeloid Cells in Metastasis.
Swierczak A; Pollard JW
Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31548218
[TBL] [Abstract][Full Text] [Related]
29. Evolution of Metastases in Space and Time under Immune Selection.
Angelova M; Mlecnik B; Vasaturo A; Bindea G; Fredriksen T; Lafontaine L; Buttard B; Morgand E; Bruni D; Jouret-Mourin A; Hubert C; Kartheuser A; Humblet Y; Ceccarelli M; Syed N; Marincola FM; Bedognetti D; Van den Eynde M; Galon J
Cell; 2018 Oct; 175(3):751-765.e16. PubMed ID: 30318143
[TBL] [Abstract][Full Text] [Related]
30. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
31. Metastasis as a systemic disease: molecular insights and clinical implications.
Alečković M; McAllister SS; Polyak K
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):89-102. PubMed ID: 31202687
[TBL] [Abstract][Full Text] [Related]
32. How do tumor stem cells actively escape from host immunosurveillance?
Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
[TBL] [Abstract][Full Text] [Related]
33. Immune cells as mediators of solid tumor metastasis.
DeNardo DG; Johansson M; Coussens LM
Cancer Metastasis Rev; 2008 Mar; 27(1):11-8. PubMed ID: 18066650
[TBL] [Abstract][Full Text] [Related]
34. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
[TBL] [Abstract][Full Text] [Related]
35. Minimal residual disease in advanced or metastatic solid cancers: The G0-G1 state and immunotherapy are key to unwinding cancer complexity.
Nicolini A; Rossi G; Ferrari P; Carpi A
Semin Cancer Biol; 2022 Feb; 79():68-82. PubMed ID: 32201368
[TBL] [Abstract][Full Text] [Related]
36. The metastasis-promoting roles of tumor-associated immune cells.
Smith HA; Kang Y
J Mol Med (Berl); 2013 Apr; 91(4):411-29. PubMed ID: 23515621
[TBL] [Abstract][Full Text] [Related]
37. Myeloid regulatory cells in tumor spreading and metastasis.
Keskinov AA; Shurin MR
Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
[TBL] [Abstract][Full Text] [Related]
38. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Maccalli C; Parmiani G; Ferrone S
Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
[TBL] [Abstract][Full Text] [Related]
40. [Immune system and tumors].
Terme M; Tanchot C
Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
